Vivani Medical Enters Material Definitive Agreement
Ticker: VANI · Form: 8-K · Filed: Mar 5, 2024 · CIK: 1266806
Sentiment: neutral
Topics: material-definitive-agreement, filing
TL;DR
VIVANI MEDICAL just signed a big deal, filing an 8-K today.
AI Summary
Vivani Medical, Inc. announced on March 1, 2024, that it entered into a Material Definitive Agreement. The company also filed financial statements and exhibits as part of this report. Specific details of the agreement and financial figures were not provided in the excerpt.
Why It Matters
This filing indicates a significant new contract or partnership for Vivani Medical, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities, the nature of which is not yet fully disclosed.
Key Numbers
- 001-36747 — SEC File Number (Identifies the company's filing history with the SEC.)
- 02-0692322 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Vivani Medical, Inc. (company) — Registrant
- March 1, 2024 (date) — Date of earliest event reported
- 1350 S. Loop Road (location) — Principal Executive Offices Address
- Alameda, California (location) — Principal Executive Offices City and State
- 94502 (location) — Principal Executive Offices Zip Code
- SECOND SIGHT MEDICAL PRODUCTS INC (company) — Former Company Name
FAQ
What is the nature of the Material Definitive Agreement?
The filing states that Vivani Medical, Inc. entered into a Material Definitive Agreement on March 1, 2024, but the specific terms and details of the agreement are not provided in the excerpt.
What are the key financial statements or exhibits filed with this 8-K?
The filing indicates that financial statements and exhibits were filed, but the excerpt does not list their specific content.
When was Vivani Medical, Inc. incorporated?
Vivani Medical, Inc. was incorporated in Delaware, as indicated by the filing.
What was the former name of Vivani Medical, Inc.?
The former name of Vivani Medical, Inc. was SECOND SIGHT MEDICAL PRODUCTS INC, with a name change date of October 10, 2003.
What is the principal business address of Vivani Medical, Inc.?
The principal executive offices are located at 1350 S. Loop Road, Alameda, California, 94502.
Filing Stats: 1,106 words · 4 min read · ~4 pages · Grade level 10.1 · Accepted 2024-03-05 16:21:35
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 VANI The Nasdaq Capital Market In
- $3.80 — to such investor at a purchase price of $3.80 per share and accompanying warrant in a
- $15.0 m — from the Offering will be approximately $15.0 million, before paying the placement agen
- $65,000 — ny also agreed to reimburse Maxim up to $65,000 for its legal expenses. The form of W
Filing Documents
- g084097_8k.htm (8-K) — 38KB
- g084097_ex4-1.htm (EX-4.1) — 93KB
- g084097_ex5-1.htm (EX-5.1) — 15KB
- g084097_ex10-1.htm (EX-10.1) — 210KB
- g084097_ex10-2.htm (EX-10.2) — 96KB
- g084097_ex99-1.htm (EX-99.1) — 19KB
- 0001753926-24-000466.txt ( ) — 750KB
- vani-20240301.xsd (EX-101.SCH) — 3KB
- vani-20240301_lab.xml (EX-101.LAB) — 33KB
- vani-20240301_pre.xml (EX-101.PRE) — 22KB
- g084097_8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 4.1* Form of Warrant. 5.1* Opinion of Goodwin Procter LLP. 10.1* Form of Securities Purchase Agreement dated March 1, 2024. 10.2* Placement Agency Agreement dated March 1, 2024. 23.1* Consent of Goodwin Procter LLP (included in Exhibit 5.1). 99.1 Press Release of the Company dated March 1, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). *Filed herewith.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Vivani Medical, Inc. Date: March 5, 2024 By: /s/ Adam Mendelsohn Adam Mendelsohn Chief Executive Officer